“Outcome of Combined Temozolomide CCNU Versus Temozolomide (Standard or Extended) For Patients With Methylated MGMT Glioblastoma”. Journal of Cancer Research Updates, vol. 15, no. 3, July 2026, pp. 197-05, https://doi.org/10.30683/1929-2279.2026.15.18.